These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14445194)

  • 1. Increase in resistance of the heart to anoxia by iproniazid.
    SETNIKAR I; RAVASI MT
    Arch Int Pharmacodyn Ther; 1960 Feb; 124():116-22. PubMed ID: 14445194
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of the effects of biogenic amines on the heart by iproniazid.
    BURFORD H; LEICK J; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1960 Oct; 128():39-50. PubMed ID: 13688979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of nialamide on coronary circulation. The influence exerted by a serotonin antagonist on the action of nialamide and of iproniazid].
    GAVEND M; GAVEND MR; MERCIER J
    C R Seances Soc Biol Fil; 1960; 154():2089-92. PubMed ID: 24545639
    [No Abstract]   [Full Text] [Related]  

  • 4. Marsilid and epinephrine metabolism.
    HOFFER A
    Dis Nerv Syst; 1959 Dec; 20():597-601. PubMed ID: 14402373
    [No Abstract]   [Full Text] [Related]  

  • 5. Catecholamine levels of brain and heart in mice after iproniazid, syrosingopine and 10-methoxydeserpidine.
    LEROY JG; DE SCHAEPDRYVER AF
    Arch Int Pharmacodyn Ther; 1961 Feb; 130():231-4. PubMed ID: 13761108
    [No Abstract]   [Full Text] [Related]  

  • 6. [QUANTITATIVE VARIATIONS OF ADENOSINE TRIPHOSPHATE IN TUBERCULOSIS PATIENTS DUE TO IPRONIAZID ACTION].
    CASTILLOBUENO A
    Medicina (Mex); 1964 Apr; 44():155-9 CONCL. PubMed ID: 14146067
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of iproniazid on survival in the dog, following acute coronary occlusion.
    REGELSON W; HOFFMEISTER FS; WILKENS H
    Ann N Y Acad Sci; 1959 Sep; 80():981-7. PubMed ID: 14436973
    [No Abstract]   [Full Text] [Related]  

  • 8. Some preliminary clinical and biochemical aspects of liver function in patients receiving iproniazid.
    ZIMMERMAN HJ; ROSENBLUM L; KORN RJ; FELDMAN PE
    Ann N Y Acad Sci; 1959 Sep; 80():915-27. PubMed ID: 13847532
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of iproniazid and other amine oxidase inhibitors.
    RANDALL LO; BAGDON RE
    Ann N Y Acad Sci; 1959 Sep; 80():626-42. PubMed ID: 14436140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of the fever inducing effect of bacterial pyrogens by iproniazid, reserpine and dibenamine].
    GOEING H
    Arzneimittelforschung; 1959 Dec; 9():793-4. PubMed ID: 13850401
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of iproniazid and pyrogallol on the hermogenic effects of noradren aline.
    JOHNSON GE; SELLERS EA
    Can J Biochem Physiol; 1962 May; 40():631-8. PubMed ID: 14452037
    [No Abstract]   [Full Text] [Related]  

  • 13. Decrease in oxygen consumption of rats by chronic iproniazid treatment.
    SETNIKAR I; MURMANN W; MAGISTRETTI MJ
    Arch Int Pharmacodyn Ther; 1960 Dec; 129():172-90. PubMed ID: 13750385
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical effects of iproniazid and similar compounds on the gastrointestinal tract.
    WEISS J; WEISS S; WEISS B
    Am J Gastroenterol; 1960 May; 33():592-9. PubMed ID: 13843721
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial hepatic study in patients treated with iproniazid.
    KATZ R; KLINGER J; SILVA L; RODRIGUEZ J; DUCCI H
    Ann N Y Acad Sci; 1959 Sep; 80():898-914. PubMed ID: 14404815
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of the hypothalamo-neurohypophysial neurosecretory system after iproniazid treatment.
    KIVALO E; RINNE UK
    Ann Med Exp Biol Fenn; 1961; 39():50-6. PubMed ID: 13756500
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the neurophysiological study of iproniazid].
    PLAS R; NAQUET R
    C R Seances Soc Biol Fil; 1961; 155():547-50. PubMed ID: 14487095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of iproniazid on hypothalamic reactions to adrenaline].
    MINZ B; THUILLIER J
    C R Seances Soc Biol Fil; 1959; 153():962-5. PubMed ID: 14422809
    [No Abstract]   [Full Text] [Related]  

  • 19. Abolition by chlorpromazine of the inhibiting effect of iproniazid on the depletion of adrenal catechol amines induced by reserpine.
    CAMANNI F; MOLINATTI GM; OLIVETTI M
    Nature; 1959 Sep; 184():65-6. PubMed ID: 13848162
    [No Abstract]   [Full Text] [Related]  

  • 20. Iproniazid and experimental lathyrism.
    JUVA K; MIKKONEN L; TUOMINEN T; KULONEN E
    Experientia; 1959 Sep; 15():350-1. PubMed ID: 14408276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.